0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Targeted Drug Detection Kit Market Research Report 2025
Published Date: 2025-05-20
|
Report Code: QYRE-Auto-29X16220
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Tumor Targeted Drug Detection Kit Market Research Report 2024
BUY CHAPTERS

Global Tumor Targeted Drug Detection Kit Market Research Report 2025

Code: QYRE-Auto-29X16220
Report
2025-05-20
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tumor Targeted Drug Detection Kit Market

The global market for Tumor Targeted Drug Detection Kit was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
This kit is an in vitro diagnostic reagent based on second-generation sequencing technology. Detection of common driver gene mutations in non-small cell lung cancer (EGFR, ALK, ROS1, BRAF, RET, ERBB2, NTRK, KRAS, etc.) and immunotherapy positive/negative/hyper-progression related genes. The types of mutations detected include point mutations, Insertions, deletions, rearrangements, fusions. The applicable sample type is paraffin-embedded tissue sample (FFPE).
North American market for Tumor Targeted Drug Detection Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tumor Targeted Drug Detection Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tumor Targeted Drug Detection Kit include BGI, Quest Diagnostics, Gene By Gene(myDNA Inc.), DNA Diagnostics Center, Invitae, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tumor Targeted Drug Detection Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Targeted Drug Detection Kit.
The Tumor Targeted Drug Detection Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Targeted Drug Detection Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Targeted Drug Detection Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tumor Targeted Drug Detection Kit Market Report

Report Metric Details
Report Name Tumor Targeted Drug Detection Kit Market
Segment by Type
  • Single Gene Testing
  • Multigene Testing
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BGI, Quest Diagnostics, Gene By Gene(myDNA Inc.), DNA Diagnostics Center, Invitae, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tumor Targeted Drug Detection Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tumor Targeted Drug Detection Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Tumor Targeted Drug Detection Kit Market report?

Ans: The main players in the Tumor Targeted Drug Detection Kit Market are BGI, Quest Diagnostics, Gene By Gene(myDNA Inc.), DNA Diagnostics Center, Invitae, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health

What are the Application segmentation covered in the Tumor Targeted Drug Detection Kit Market report?

Ans: The Applications covered in the Tumor Targeted Drug Detection Kit Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Tumor Targeted Drug Detection Kit Market report?

Ans: The Types covered in the Tumor Targeted Drug Detection Kit Market report are Single Gene Testing, Multigene Testing

1 Tumor Targeted Drug Detection Kit Market Overview
1.1 Product Definition
1.2 Tumor Targeted Drug Detection Kit by Type
1.2.1 Global Tumor Targeted Drug Detection Kit Market Value Comparison by Type (2024 VS 2031)
1.2.2 Single Gene Testing
1.2.3 Multigene Testing
1.3 Tumor Targeted Drug Detection Kit by Application
1.3.1 Global Tumor Targeted Drug Detection Kit Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Tumor Targeted Drug Detection Kit Market Size Estimates and Forecasts
1.4.1 Global Tumor Targeted Drug Detection Kit Revenue 2020-2031
1.4.2 Global Tumor Targeted Drug Detection Kit Sales 2020-2031
1.4.3 Global Tumor Targeted Drug Detection Kit Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tumor Targeted Drug Detection Kit Market Competition by Manufacturers
2.1 Global Tumor Targeted Drug Detection Kit Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tumor Targeted Drug Detection Kit Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tumor Targeted Drug Detection Kit Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tumor Targeted Drug Detection Kit, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tumor Targeted Drug Detection Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Targeted Drug Detection Kit, Product Type & Application
2.7 Global Key Manufacturers of Tumor Targeted Drug Detection Kit, Date of Enter into This Industry
2.8 Global Tumor Targeted Drug Detection Kit Market Competitive Situation and Trends
2.8.1 Global Tumor Targeted Drug Detection Kit Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tumor Targeted Drug Detection Kit Players Market Share by Revenue
2.8.3 Global Tumor Targeted Drug Detection Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tumor Targeted Drug Detection Kit Market Scenario by Region
3.1 Global Tumor Targeted Drug Detection Kit Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tumor Targeted Drug Detection Kit Sales by Region: 2020-2031
3.2.1 Global Tumor Targeted Drug Detection Kit Sales by Region: 2020-2025
3.2.2 Global Tumor Targeted Drug Detection Kit Sales by Region: 2026-2031
3.3 Global Tumor Targeted Drug Detection Kit Revenue by Region: 2020-2031
3.3.1 Global Tumor Targeted Drug Detection Kit Revenue by Region: 2020-2025
3.3.2 Global Tumor Targeted Drug Detection Kit Revenue by Region: 2026-2031
3.4 North America Tumor Targeted Drug Detection Kit Market Facts & Figures by Country
3.4.1 North America Tumor Targeted Drug Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tumor Targeted Drug Detection Kit Sales by Country (2020-2031)
3.4.3 North America Tumor Targeted Drug Detection Kit Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumor Targeted Drug Detection Kit Market Facts & Figures by Country
3.5.1 Europe Tumor Targeted Drug Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tumor Targeted Drug Detection Kit Sales by Country (2020-2031)
3.5.3 Europe Tumor Targeted Drug Detection Kit Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Targeted Drug Detection Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Tumor Targeted Drug Detection Kit Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tumor Targeted Drug Detection Kit Sales by Region (2020-2031)
3.6.3 Asia Pacific Tumor Targeted Drug Detection Kit Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tumor Targeted Drug Detection Kit Market Facts & Figures by Country
3.7.1 Latin America Tumor Targeted Drug Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tumor Targeted Drug Detection Kit Sales by Country (2020-2031)
3.7.3 Latin America Tumor Targeted Drug Detection Kit Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tumor Targeted Drug Detection Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Targeted Drug Detection Kit Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tumor Targeted Drug Detection Kit Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tumor Targeted Drug Detection Kit Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Targeted Drug Detection Kit Sales by Type (2020-2031)
4.1.1 Global Tumor Targeted Drug Detection Kit Sales by Type (2020-2025)
4.1.2 Global Tumor Targeted Drug Detection Kit Sales by Type (2026-2031)
4.1.3 Global Tumor Targeted Drug Detection Kit Sales Market Share by Type (2020-2031)
4.2 Global Tumor Targeted Drug Detection Kit Revenue by Type (2020-2031)
4.2.1 Global Tumor Targeted Drug Detection Kit Revenue by Type (2020-2025)
4.2.2 Global Tumor Targeted Drug Detection Kit Revenue by Type (2026-2031)
4.2.3 Global Tumor Targeted Drug Detection Kit Revenue Market Share by Type (2020-2031)
4.3 Global Tumor Targeted Drug Detection Kit Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tumor Targeted Drug Detection Kit Sales by Application (2020-2031)
5.1.1 Global Tumor Targeted Drug Detection Kit Sales by Application (2020-2025)
5.1.2 Global Tumor Targeted Drug Detection Kit Sales by Application (2026-2031)
5.1.3 Global Tumor Targeted Drug Detection Kit Sales Market Share by Application (2020-2031)
5.2 Global Tumor Targeted Drug Detection Kit Revenue by Application (2020-2031)
5.2.1 Global Tumor Targeted Drug Detection Kit Revenue by Application (2020-2025)
5.2.2 Global Tumor Targeted Drug Detection Kit Revenue by Application (2026-2031)
5.2.3 Global Tumor Targeted Drug Detection Kit Revenue Market Share by Application (2020-2031)
5.3 Global Tumor Targeted Drug Detection Kit Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BGI
6.1.1 BGI Company Information
6.1.2 BGI Description and Business Overview
6.1.3 BGI Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BGI Tumor Targeted Drug Detection Kit Product Portfolio
6.1.5 BGI Recent Developments/Updates
6.2 Quest Diagnostics
6.2.1 Quest Diagnostics Company Information
6.2.2 Quest Diagnostics Description and Business Overview
6.2.3 Quest Diagnostics Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Quest Diagnostics Tumor Targeted Drug Detection Kit Product Portfolio
6.2.5 Quest Diagnostics Recent Developments/Updates
6.3 Gene By Gene(myDNA Inc.)
6.3.1 Gene By Gene(myDNA Inc.) Company Information
6.3.2 Gene By Gene(myDNA Inc.) Description and Business Overview
6.3.3 Gene By Gene(myDNA Inc.) Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gene By Gene(myDNA Inc.) Tumor Targeted Drug Detection Kit Product Portfolio
6.3.5 Gene By Gene(myDNA Inc.) Recent Developments/Updates
6.4 DNA Diagnostics Center
6.4.1 DNA Diagnostics Center Company Information
6.4.2 DNA Diagnostics Center Description and Business Overview
6.4.3 DNA Diagnostics Center Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.4.4 DNA Diagnostics Center Tumor Targeted Drug Detection Kit Product Portfolio
6.4.5 DNA Diagnostics Center Recent Developments/Updates
6.5 Invitae
6.5.1 Invitae Company Information
6.5.2 Invitae Description and Business Overview
6.5.3 Invitae Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Invitae Tumor Targeted Drug Detection Kit Product Portfolio
6.5.5 Invitae Recent Developments/Updates
6.6 Ambry Genetics
6.6.1 Ambry Genetics Company Information
6.6.2 Ambry Genetics Description and Business Overview
6.6.3 Ambry Genetics Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ambry Genetics Tumor Targeted Drug Detection Kit Product Portfolio
6.6.5 Ambry Genetics Recent Developments/Updates
6.7 Living DNA
6.7.1 Living DNA Company Information
6.7.2 Living DNA Description and Business Overview
6.7.3 Living DNA Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Living DNA Tumor Targeted Drug Detection Kit Product Portfolio
6.7.5 Living DNA Recent Developments/Updates
6.8 EasyDNA
6.8.1 EasyDNA Company Information
6.8.2 EasyDNA Description and Business Overview
6.8.3 EasyDNA Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.8.4 EasyDNA Tumor Targeted Drug Detection Kit Product Portfolio
6.8.5 EasyDNA Recent Developments/Updates
6.9 Pathway Genomics
6.9.1 Pathway Genomics Company Information
6.9.2 Pathway Genomics Description and Business Overview
6.9.3 Pathway Genomics Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pathway Genomics Tumor Targeted Drug Detection Kit Product Portfolio
6.9.5 Pathway Genomics Recent Developments/Updates
6.10 Centrillion Technology
6.10.1 Centrillion Technology Company Information
6.10.2 Centrillion Technology Description and Business Overview
6.10.3 Centrillion Technology Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Centrillion Technology Tumor Targeted Drug Detection Kit Product Portfolio
6.10.5 Centrillion Technology Recent Developments/Updates
6.11 Color Genomics
6.11.1 Color Genomics Company Information
6.11.2 Color Genomics Description and Business Overview
6.11.3 Color Genomics Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Color Genomics Tumor Targeted Drug Detection Kit Product Portfolio
6.11.5 Color Genomics Recent Developments/Updates
6.12 Anglia DNA Services
6.12.1 Anglia DNA Services Company Information
6.12.2 Anglia DNA Services Description and Business Overview
6.12.3 Anglia DNA Services Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Anglia DNA Services Tumor Targeted Drug Detection Kit Product Portfolio
6.12.5 Anglia DNA Services Recent Developments/Updates
6.13 African Ancestry
6.13.1 African Ancestry Company Information
6.13.2 African Ancestry Description and Business Overview
6.13.3 African Ancestry Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.13.4 African Ancestry Tumor Targeted Drug Detection Kit Product Portfolio
6.13.5 African Ancestry Recent Developments/Updates
6.14 Canadian DNA Services
6.14.1 Canadian DNA Services Company Information
6.14.2 Canadian DNA Services Description and Business Overview
6.14.3 Canadian DNA Services Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Canadian DNA Services Tumor Targeted Drug Detection Kit Product Portfolio
6.14.5 Canadian DNA Services Recent Developments/Updates
6.15 DNA Family Check
6.15.1 DNA Family Check Company Information
6.15.2 DNA Family Check Description and Business Overview
6.15.3 DNA Family Check Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.15.4 DNA Family Check Tumor Targeted Drug Detection Kit Product Portfolio
6.15.5 DNA Family Check Recent Developments/Updates
6.16 Alpha Biolaboratories
6.16.1 Alpha Biolaboratories Company Information
6.16.2 Alpha Biolaboratories Description and Business Overview
6.16.3 Alpha Biolaboratories Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Alpha Biolaboratories Tumor Targeted Drug Detection Kit Product Portfolio
6.16.5 Alpha Biolaboratories Recent Developments/Updates
6.17 Test Me DNA
6.17.1 Test Me DNA Company Information
6.17.2 Test Me DNA Description and Business Overview
6.17.3 Test Me DNA Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Test Me DNA Tumor Targeted Drug Detection Kit Product Portfolio
6.17.5 Test Me DNA Recent Developments/Updates
6.18 23 Mofang
6.18.1 23 Mofang Company Information
6.18.2 23 Mofang Description and Business Overview
6.18.3 23 Mofang Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.18.4 23 Mofang Tumor Targeted Drug Detection Kit Product Portfolio
6.18.5 23 Mofang Recent Developments/Updates
6.19 Genetic Health
6.19.1 Genetic Health Company Information
6.19.2 Genetic Health Description and Business Overview
6.19.3 Genetic Health Tumor Targeted Drug Detection Kit Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Genetic Health Tumor Targeted Drug Detection Kit Product Portfolio
6.19.5 Genetic Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Targeted Drug Detection Kit Industry Chain Analysis
7.2 Tumor Targeted Drug Detection Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Targeted Drug Detection Kit Production Mode & Process Analysis
7.4 Tumor Targeted Drug Detection Kit Sales and Marketing
7.4.1 Tumor Targeted Drug Detection Kit Sales Channels
7.4.2 Tumor Targeted Drug Detection Kit Distributors
7.5 Tumor Targeted Drug Detection Kit Customer Analysis
8 Tumor Targeted Drug Detection Kit Market Dynamics
8.1 Tumor Targeted Drug Detection Kit Industry Trends
8.2 Tumor Targeted Drug Detection Kit Market Drivers
8.3 Tumor Targeted Drug Detection Kit Market Challenges
8.4 Tumor Targeted Drug Detection Kit Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Tumor Targeted Drug Detection Kit Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tumor Targeted Drug Detection Kit Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tumor Targeted Drug Detection Kit Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tumor Targeted Drug Detection Kit Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Tumor Targeted Drug Detection Kit Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tumor Targeted Drug Detection Kit Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tumor Targeted Drug Detection Kit Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tumor Targeted Drug Detection Kit Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tumor Targeted Drug Detection Kit, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tumor Targeted Drug Detection Kit, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tumor Targeted Drug Detection Kit, Product Type & Application
 Table 12. Global Key Manufacturers of Tumor Targeted Drug Detection Kit, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tumor Targeted Drug Detection Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Targeted Drug Detection Kit as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tumor Targeted Drug Detection Kit Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tumor Targeted Drug Detection Kit Sales by Region (2020-2025) & (K Units)
 Table 18. Global Tumor Targeted Drug Detection Kit Sales Market Share by Region (2020-2025)
 Table 19. Global Tumor Targeted Drug Detection Kit Sales by Region (2026-2031) & (K Units)
 Table 20. Global Tumor Targeted Drug Detection Kit Sales Market Share by Region (2026-2031)
 Table 21. Global Tumor Targeted Drug Detection Kit Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tumor Targeted Drug Detection Kit Revenue Market Share by Region (2020-2025)
 Table 23. Global Tumor Targeted Drug Detection Kit Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tumor Targeted Drug Detection Kit Revenue Market Share by Region (2026-2031)
 Table 25. North America Tumor Targeted Drug Detection Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tumor Targeted Drug Detection Kit Sales by Country (2020-2025) & (K Units)
 Table 27. North America Tumor Targeted Drug Detection Kit Sales by Country (2026-2031) & (K Units)
 Table 28. North America Tumor Targeted Drug Detection Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tumor Targeted Drug Detection Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tumor Targeted Drug Detection Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tumor Targeted Drug Detection Kit Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Tumor Targeted Drug Detection Kit Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Tumor Targeted Drug Detection Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tumor Targeted Drug Detection Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tumor Targeted Drug Detection Kit Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tumor Targeted Drug Detection Kit Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Tumor Targeted Drug Detection Kit Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Tumor Targeted Drug Detection Kit Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tumor Targeted Drug Detection Kit Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tumor Targeted Drug Detection Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tumor Targeted Drug Detection Kit Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Tumor Targeted Drug Detection Kit Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Tumor Targeted Drug Detection Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tumor Targeted Drug Detection Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tumor Targeted Drug Detection Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tumor Targeted Drug Detection Kit Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Tumor Targeted Drug Detection Kit Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Tumor Targeted Drug Detection Kit Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tumor Targeted Drug Detection Kit Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tumor Targeted Drug Detection Kit Sales (K Units) by Type (2020-2025)
 Table 51. Global Tumor Targeted Drug Detection Kit Sales (K Units) by Type (2026-2031)
 Table 52. Global Tumor Targeted Drug Detection Kit Sales Market Share by Type (2020-2025)
 Table 53. Global Tumor Targeted Drug Detection Kit Sales Market Share by Type (2026-2031)
 Table 54. Global Tumor Targeted Drug Detection Kit Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tumor Targeted Drug Detection Kit Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tumor Targeted Drug Detection Kit Revenue Market Share by Type (2020-2025)
 Table 57. Global Tumor Targeted Drug Detection Kit Revenue Market Share by Type (2026-2031)
 Table 58. Global Tumor Targeted Drug Detection Kit Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Tumor Targeted Drug Detection Kit Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Tumor Targeted Drug Detection Kit Sales (K Units) by Application (2020-2025)
 Table 61. Global Tumor Targeted Drug Detection Kit Sales (K Units) by Application (2026-2031)
 Table 62. Global Tumor Targeted Drug Detection Kit Sales Market Share by Application (2020-2025)
 Table 63. Global Tumor Targeted Drug Detection Kit Sales Market Share by Application (2026-2031)
 Table 64. Global Tumor Targeted Drug Detection Kit Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tumor Targeted Drug Detection Kit Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tumor Targeted Drug Detection Kit Revenue Market Share by Application (2020-2025)
 Table 67. Global Tumor Targeted Drug Detection Kit Revenue Market Share by Application (2026-2031)
 Table 68. Global Tumor Targeted Drug Detection Kit Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Tumor Targeted Drug Detection Kit Price (US$/Unit) by Application (2026-2031)
 Table 70. BGI Company Information
 Table 71. BGI Description and Business Overview
 Table 72. BGI Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. BGI Tumor Targeted Drug Detection Kit Product
 Table 74. BGI Recent Developments/Updates
 Table 75. Quest Diagnostics Company Information
 Table 76. Quest Diagnostics Description and Business Overview
 Table 77. Quest Diagnostics Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Quest Diagnostics Tumor Targeted Drug Detection Kit Product
 Table 79. Quest Diagnostics Recent Developments/Updates
 Table 80. Gene By Gene(myDNA Inc.) Company Information
 Table 81. Gene By Gene(myDNA Inc.) Description and Business Overview
 Table 82. Gene By Gene(myDNA Inc.) Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Gene By Gene(myDNA Inc.) Tumor Targeted Drug Detection Kit Product
 Table 84. Gene By Gene(myDNA Inc.) Recent Developments/Updates
 Table 85. DNA Diagnostics Center Company Information
 Table 86. DNA Diagnostics Center Description and Business Overview
 Table 87. DNA Diagnostics Center Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. DNA Diagnostics Center Tumor Targeted Drug Detection Kit Product
 Table 89. DNA Diagnostics Center Recent Developments/Updates
 Table 90. Invitae Company Information
 Table 91. Invitae Description and Business Overview
 Table 92. Invitae Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Invitae Tumor Targeted Drug Detection Kit Product
 Table 94. Invitae Recent Developments/Updates
 Table 95. Ambry Genetics Company Information
 Table 96. Ambry Genetics Description and Business Overview
 Table 97. Ambry Genetics Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Ambry Genetics Tumor Targeted Drug Detection Kit Product
 Table 99. Ambry Genetics Recent Developments/Updates
 Table 100. Living DNA Company Information
 Table 101. Living DNA Description and Business Overview
 Table 102. Living DNA Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Living DNA Tumor Targeted Drug Detection Kit Product
 Table 104. Living DNA Recent Developments/Updates
 Table 105. EasyDNA Company Information
 Table 106. EasyDNA Description and Business Overview
 Table 107. EasyDNA Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. EasyDNA Tumor Targeted Drug Detection Kit Product
 Table 109. EasyDNA Recent Developments/Updates
 Table 110. Pathway Genomics Company Information
 Table 111. Pathway Genomics Description and Business Overview
 Table 112. Pathway Genomics Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Pathway Genomics Tumor Targeted Drug Detection Kit Product
 Table 114. Pathway Genomics Recent Developments/Updates
 Table 115. Centrillion Technology Company Information
 Table 116. Centrillion Technology Description and Business Overview
 Table 117. Centrillion Technology Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Centrillion Technology Tumor Targeted Drug Detection Kit Product
 Table 119. Centrillion Technology Recent Developments/Updates
 Table 120. Color Genomics Company Information
 Table 121. Color Genomics Description and Business Overview
 Table 122. Color Genomics Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Color Genomics Tumor Targeted Drug Detection Kit Product
 Table 124. Color Genomics Recent Developments/Updates
 Table 125. Anglia DNA Services Company Information
 Table 126. Anglia DNA Services Description and Business Overview
 Table 127. Anglia DNA Services Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Anglia DNA Services Tumor Targeted Drug Detection Kit Product
 Table 129. Anglia DNA Services Recent Developments/Updates
 Table 130. African Ancestry Company Information
 Table 131. African Ancestry Description and Business Overview
 Table 132. African Ancestry Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. African Ancestry Tumor Targeted Drug Detection Kit Product
 Table 134. African Ancestry Recent Developments/Updates
 Table 135. Canadian DNA Services Company Information
 Table 136. Canadian DNA Services Description and Business Overview
 Table 137. Canadian DNA Services Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Canadian DNA Services Tumor Targeted Drug Detection Kit Product
 Table 139. Canadian DNA Services Recent Developments/Updates
 Table 140. DNA Family Check Company Information
 Table 141. DNA Family Check Description and Business Overview
 Table 142. DNA Family Check Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. DNA Family Check Tumor Targeted Drug Detection Kit Product
 Table 144. DNA Family Check Recent Developments/Updates
 Table 145. Alpha Biolaboratories Company Information
 Table 146. Alpha Biolaboratories Description and Business Overview
 Table 147. Alpha Biolaboratories Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Alpha Biolaboratories Tumor Targeted Drug Detection Kit Product
 Table 149. Alpha Biolaboratories Recent Developments/Updates
 Table 150. Test Me DNA Company Information
 Table 151. Test Me DNA Description and Business Overview
 Table 152. Test Me DNA Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Test Me DNA Tumor Targeted Drug Detection Kit Product
 Table 154. Test Me DNA Recent Developments/Updates
 Table 155. 23 Mofang Company Information
 Table 156. 23 Mofang Description and Business Overview
 Table 157. 23 Mofang Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. 23 Mofang Tumor Targeted Drug Detection Kit Product
 Table 159. 23 Mofang Recent Developments/Updates
 Table 160. Genetic Health Company Information
 Table 161. Genetic Health Description and Business Overview
 Table 162. Genetic Health Tumor Targeted Drug Detection Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Genetic Health Tumor Targeted Drug Detection Kit Product
 Table 164. Genetic Health Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Tumor Targeted Drug Detection Kit Distributors List
 Table 168. Tumor Targeted Drug Detection Kit Customers List
 Table 169. Tumor Targeted Drug Detection Kit Market Trends
 Table 170. Tumor Targeted Drug Detection Kit Market Drivers
 Table 171. Tumor Targeted Drug Detection Kit Market Challenges
 Table 172. Tumor Targeted Drug Detection Kit Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tumor Targeted Drug Detection Kit
 Figure 2. Global Tumor Targeted Drug Detection Kit Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tumor Targeted Drug Detection Kit Market Share by Type: 2024 & 2031
 Figure 4. Single Gene Testing Product Picture
 Figure 5. Multigene Testing Product Picture
 Figure 6. Global Tumor Targeted Drug Detection Kit Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Tumor Targeted Drug Detection Kit Market Share by Application: 2024 & 2031
 Figure 8. Online Sales
 Figure 9. Offline Sales
 Figure 10. Global Tumor Targeted Drug Detection Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Tumor Targeted Drug Detection Kit Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Tumor Targeted Drug Detection Kit Sales (2020-2031) & (K Units)
 Figure 13. Global Tumor Targeted Drug Detection Kit Average Price (US$/Unit) & (2020-2031)
 Figure 14. Tumor Targeted Drug Detection Kit Report Years Considered
 Figure 15. Tumor Targeted Drug Detection Kit Sales Share by Manufacturers in 2024
 Figure 16. Global Tumor Targeted Drug Detection Kit Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Tumor Targeted Drug Detection Kit Players: Market Share by Revenue in Tumor Targeted Drug Detection Kit in 2024
 Figure 18. Tumor Targeted Drug Detection Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Tumor Targeted Drug Detection Kit Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Tumor Targeted Drug Detection Kit Sales Market Share by Country (2020-2031)
 Figure 21. North America Tumor Targeted Drug Detection Kit Revenue Market Share by Country (2020-2031)
 Figure 22. United States Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Tumor Targeted Drug Detection Kit Sales Market Share by Country (2020-2031)
 Figure 25. Europe Tumor Targeted Drug Detection Kit Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Tumor Targeted Drug Detection Kit Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Tumor Targeted Drug Detection Kit Revenue Market Share by Region (2020-2031)
 Figure 33. China Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Tumor Targeted Drug Detection Kit Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Tumor Targeted Drug Detection Kit Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Tumor Targeted Drug Detection Kit Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Tumor Targeted Drug Detection Kit Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Tumor Targeted Drug Detection Kit Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Tumor Targeted Drug Detection Kit by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Tumor Targeted Drug Detection Kit by Type (2020-2031)
 Figure 52. Global Tumor Targeted Drug Detection Kit Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Tumor Targeted Drug Detection Kit by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Tumor Targeted Drug Detection Kit by Application (2020-2031)
 Figure 55. Global Tumor Targeted Drug Detection Kit Price (US$/Unit) by Application (2020-2031)
 Figure 56. Tumor Targeted Drug Detection Kit Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS